42 Interestingly, findings from an ultra-long-term CR study (mean duration: 6.8 years
Based on collective human data, a glycemic threshold of 99 108 mg/dL may exist, below which GIP primarily exerts glucagonotropic actions (35)
From the GLP Collection range, handled with the same preparation steps as this one
When used under medical supervision, they may support steady, sustainable weight loss
Cleveland Clinic describes GLP-1 agonists as a class of medications that mainly help manage blood sugar levels for people with T2D, but notes that due to the drugs satiety effect, they can often promote weight loss
Bariatric surgery has decades of long-term research showing sustained weight loss, while the long-term effects of GLP-1 medications are still being studied.